Seibyl JP - Search Results

1

Change in PDE10 across early Huntington disease assessed by [18F]MNI-659 and PET imaging.

Russell DS, Jennings DL, Barret O, Tamagnan GD, Carroll VM, Caillé F, Alagille D, Morley TJ, Papin C, Seibyl JP, Marek KL. Russell DS, et al. Among authors: seibyl jp. Neurology. 2016 Feb 23;86(8):748-54. doi: 10.1212/WNL.0000000000002391. Epub 2016 Jan 22. Neurology. 2016. PMID: 26802091

2

"Central" and "peripheral" benzodiazepine receptors: opposite changes in human epileptogenic tissue.

Johnson EW, de Lanerolle NC, Kim JH, Sundaresan S, Spencer DD, Mattson RH, Zoghbi SS, Baldwin RM, Hoffer PB, Seibyl JP, et al. Johnson EW, et al. Among authors: seibyl jp. Neurology. 1992 Apr;42(4):811-5. doi: 10.1212/wnl.42.4.811. Neurology. 1992. PMID: 1314342

3

Decreased single-photon emission computed tomographic [123I]beta-CIT striatal uptake correlates with symptom severity in Parkinson's disease.

Seibyl JP, Marek KL, Quinlan D, Sheff K, Zoghbi S, Zea-Ponce Y, Baldwin RM, Fussell B, Smith EO, Charney DS, van Dyck C, et al. Seibyl JP, et al. Ann Neurol. 1995 Oct;38(4):589-98. doi: 10.1002/ana.410380407. Ann Neurol. 1995. PMID: 7574455

4

[123I] beta-CIT/SPECT imaging demonstrates bilateral loss of dopamine transporters in hemi-Parkinson's disease.

Marek KL, Seibyl JP, Zoghbi SS, Zea-Ponce Y, Baldwin RM, Fussell B, Charney DS, van Dyck C, Hoffer PB, Innis RP. Marek KL, et al. Among authors: seibyl jp. Neurology. 1996 Jan;46(1):231-7. doi: 10.1212/wnl.46.1.231. Neurology. 1996. PMID: 8559382

5

Images in neuroscience. Neuroimaging, XII. SPECT imaging of dopamine nerve terminals.

Seibyl JP, Marek K, Innis RB. Seibyl JP, et al. Am J Psychiatry. 1996 Sep;153(9):1131. doi: 10.1176/ajp.153.9.1131. Am J Psychiatry. 1996. PMID: 8780413 No abstract available.

6

Test/retest reproducibility of iodine-123-betaCIT SPECT brain measurement of dopamine transporters in Parkinson's patients.

Seibyl JP, Marek K, Sheff K, Baldwin RM, Zoghbi S, Zea-Ponce Y, Charney DS, van Dyck CH, Hoffer PB, Innis RB. Seibyl JP, et al. J Nucl Med. 1997 Sep;38(9):1453-9. J Nucl Med. 1997. PMID: 9293807 Free article.

7

Iodine-123-beta-CIT and iodine-123-FPCIT SPECT measurement of dopamine transporters in healthy subjects and Parkinson's patients.

Seibyl JP, Marek K, Sheff K, Zoghbi S, Baldwin RM, Charney DS, van Dyck CH, Innis RB. Seibyl JP, et al. J Nucl Med. 1998 Sep;39(9):1500-8. J Nucl Med. 1998. PMID: 9744331 Free article.

8

Effect of treatment with L-dopa/carbidopa or L-selegiline on striatal dopamine transporter SPECT imaging with [123I]beta-CIT.

Innis RB, Marek KL, Sheff K, Zoghbi S, Castronuovo J, Feigin A, Seibyl JP. Innis RB, et al. Among authors: seibyl jp. Mov Disord. 1999 May;14(3):436-42. doi: 10.1002/1531-8257(199905)14:3<436::aid-mds1008>3.0.co;2-j. Mov Disord. 1999. PMID: 10348466 Clinical Trial.

9

TechSight. Imaging. A molecular map for neurodegeneration.

Marek K, Seibyl J. Marek K, et al. Science. 2000 Jul 21;289(5478):409-11. doi: 10.1126/science.289.5478.409. Science. 2000. PMID: 10939953 No abstract available.

10

Measurement of alpha4beta2 nicotinic acetylcholine receptors with [123I]5-I-A-85380 SPECT.

Fujita M, Tamagnan G, Zoghbi SS, Al-Tikriti MS, Baldwin RM, Seibyl JP, Innis RB. Fujita M, et al. Among authors: seibyl jp. J Nucl Med. 2000 Sep;41(9):1552-60. J Nucl Med. 2000. PMID: 10994738 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

301 results

Search Page

Filters